Effect of surfactant protein A on the physical properties and surface activity of KL4-surfactant

Biophysical Journal

Volumn 92, Issue 2, 2007, Pages 482-492

  Sáenz, Alejandra ^a   Cañadas, Olga ^a   Bagatolli, Luís A ^b   Sánchez Barbero, Fernando ^a   Johnson, Mark E ^c   Casals, Cristina ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Discovery Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOSOME; LUNG SURFACTANT; LYSYLLEUCYLLEUCYLLEUCYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLYSINE; SURFACTANT; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MECHANISM; HUMAN; NONHUMAN; PROTEIN ISOLATION; SURFACE PROPERTY;

ANIMALIA;

EID: 33846432384     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.090217     Document Type: Article

References (58)

1. Johansson, J., and T. Curstedt. 1997. Molecular structures and interactions of pulmonary surfactant components. Eur. J. Biochem. 244:675-693.
2. Hawgood, S. 1997. Surfactant: composition, structure, and metabolism. In The Lung: Scientific Foundations, 2nd Ed. R. G. Crystal, J. B. West, P. J. Barnes, and E. R. Weibel, editors. Lippincott-Raven Publishers, Philadelphia, PA. 557-571.
3. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nature Rev. Immunol. 5:58-68.
4. Whitsett, J. A., and T. E. Weaver. 2002. Hydrophobic surfactant proteins in lung function and disease. N. Engl. J. Med. 347:2141-2148.
5. Robertson, B., and H. L. Halliday. 1998. Principles of surfactant replacement. Biochim. Biophys. Acta. 1408:346-361.
6. Casals, C., and I. García-Verdugo. 2005. Molecular and functional properties of surfactant protein A. In Developments in Lung Surfactant Dysfunction in Lung Biology in Health and Disease. K. Nag, editor. Marcel Dekker, New York. 55-84.
7. Casals, C. 2001. Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung. Pediatr. Pathol. Mol. Med. 20:249-268.
8. Hawgood, S., B. J. Benson, J. Schilling, D. Damm, J. A. Clements, and R. T. White. 1987. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc. Natl. Acad. Sci. USA. 84:66-70.
9. Cockshutt, A. M., J. Weitz, and F. Possmayer. 1990. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry. 29:8424-8429.
10. Ikegami, M., T. R. Korfhagen, J. A. Whitsett, M. D. Bruno, S. E. Wert, K. Wada, and A. H. Jobe. 1998. Characteristics of surfactant from SPA-deficient mice. Am. J. Physiol. 275:L247-L254.
11. Ingenito, E. P., L. Mark, J. Morris, F. F. Espinosa, R. D. Kamm, and M. Johnson. 1999. Biophysical characterization and modeling of lung surfactant components. J. Appl. Physiol. 86:1702-1714.
12. Bernhard, W., J. Mottaghian, A. Gebert, G. A. Rau, H. von Der Hardt, and C. F. Poets. 2000. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am. J. Respir. Crit. Care Med. 162:1524-1533.
13. Yamada, T., M. Ikegami, B. L. Tabor, and A. H. Jobe. 1990. Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits. Am. Rev. Respir. Dis. 142:754-757.
14. Sun, B., T. Curstedt, G. Lindgren, B. Franzen, A. A. Alaiya, A. Calkovska, and B. Robertson. 1997. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur. Respir. J. 10:1967-1974.
15. Robertson, B., J. Johansson, and T. Curstedt. 2000. Synthetic surfactants to treat neonatal lung disease. Mol. Med. Today. 6:119-124.
16. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science. 254:566-568.
17. Saenz, A., O. Canadas, L. A. Bagatolli, M. E. Johnson, and C. Casals. 2006. Physical properties and surface activity of surfactant-like membranes containing the cationic and the hydrophobic peptide KL4. FEBS J. 273:2515-2527.
18. Ma, J., S. Koppenol, H. Yu, and G. Zografi. 1998. Effects of a cationic and hydrophobic peptide, KL4, on model lung surfactant lipid monolayers. Biophys. J. 74:1899-1907.
19. Nilsson, G., M. Gustafsson, G. Vandenbussche, E. Veldhuizen, W. J. Griffiths, J. Sjovall, H. P. Haagsman, J. M. Ruysschaert, B. Robertson, T. Curstedt, and J. Johansson. 1998. Synthetic peptide-containing surfactants - evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. Eur. J. Biochem. 255:116-124.
20. Cochrane, C. G., S. D. Revak, T. A. Merritt, G. P. Heldt, M. Hallman, M. D. Cunningham, D. Easa, A. Pramanik, D. K. Edwards, and M. S. Alberts. 1996. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:404-410.
21. Sinha, S. K., T. Lacaze-Masmonteil, A. Valls i Soler, T. E. Wiswell, J. Gadzinowski, J. Hajdu, G. Bernstein, M. Sanchez-Luna, R. Segal, C. J. Schaber, J. Massaro, and R. d'Agostino. 2005. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 115:1030-1038.
22. Cochrane, C. G., S. D. Revak, T. A. Merritt, I. U. Schraufstatter, R. C. Hoch, C. Henderson, S. Andersson, H. Takamori, and Z. G. Oades. 1998. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr. Res. 44:705-715.
23. Wiswell, T. E., G. R. Knight, N. N. Finer, S. M. Donn, H. Desai, W. F. Walsh, K. C. Sekar, G. Bernstein, M. Keszler, V. E. Visser, T. A. Merritt, F. L. Mannino, L. Mastrioianni, B. Marcy, S. D. Revak, H. Tsai, and C. G. Cochrane. 2002. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics. 109:1081-1087.
24. Wiswell, T. E., R. M. Smith, L. B. Katz, L. Mastroianni, D. Y. Wong, D. Willms, S. Heard, M. Wilson, R. D. Hite, A. Anzueto, S. D. Revak, and C. G. Cochrane. 1999. Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 160:1188-1195.
25. Ruano, M. L. F., J. Perez-Gil, and C. Casals. 1998. Effect of acidic pH on the structure and lipid binding properties of porcine surfactant protein A. Potential role of acidification along its exocytic pathway. J. Biol. Chem. 273:15183-15191.
26. Sanchez-Barbero, F., J. Strassner, R. Garcia-Canero, W. Steinhilber, and C. Casals. 2005. Role of the degree of oligomerization in the structure and function of human surfactant protein A. J. Biol. Chem. 280:7659-7670.
27. Garcia-Verdugo, I., F. Sanchez-Barbero, F. U. Bosch, W. Steinhilber, and C. Casals. 2003. Effect of hydroxylation and N187-linked glycosylation on molecular and functional properties of recombinant human surfactant protein A. Biochemistry. 42:9532-9542.
28. Casals, C., L. Herrera, E. Miguel, P. Garcia-Barreno, and A. M. Municio. 1989. Comparison between intra- and extracellular surfactant in respiratory distress induced by oleic acid. Biochim. Biophys. Acta. 1003:201-203.
29. Casals, C., A. Varela, M. L. Ruano, F. Valino, J. Perez-Gil, N. Torre, E. Jorge, F. Tendillo, and J. L. Castillo-Olivares. 1998. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am. J. Respir. Crit. Care Med. 157:43-49.
30. Oviedo, J. M., F. Valiño, I. Plasencia, A. G. Serrano, C. Casals, and J. Pérez-Gil. 2001. Quantitation of pulmonary surfactant protein SP-B in the absence or presence of phospholipids by enzyme-linked immunosorbent assay. Anal. Biochem. 293:78-87.
31. Schmidt, R., W. Steinhilber, C. Ruppert, C. Daum, F. Grimminger, W. Seeger, and A. Gunther. 2002. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 165:470-474.
32. Canadas, O., R. Guerrero, R. Garcia-Canero, G. Orellana, M. Menendez, and C. Casals. 2004. Characterization of liposomal tacrolimus in lung surfactant-like phospholipids and evaluation of its immunosuppressive activity. Biochemistry. 43:9926-9938.
33. Bernardino de la Serna, J., J. Perez-Gil, A. C. Simonsen, and L. A. Bagatolli. 2004. Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J. Biol. Chem. 279:40715-40722.
34. Angelova, M. I., and D. S. Dimitrov. 1986. Liposome electroformation. Faraday Discuss. Chem. Soc. 81:303-311.
35. Bagatolli, L. A., and E. Gratton. 2000. Two photon fluorescence microscopy of coexisting lipid domains in giant unilamellar vesicles of binary phospholipid mixtures. Biophys. J. 78:290-305.
36. Akashi, K., H. Miyata, H. Itoh, and K. Kinosita Jr. 1996. Preparation of giant liposomes in physiological conditions and their characterization under an optical microscope. Biophys. J. 71:3242-3250.
37. Lakowicz, J. R. 1999. Principles of Fluorescence Spectroscopy. Kluwer Academic/Plenum, New York.
38. Huang, N. N., K. Florine-Casteel, G. W. Feigenson, and C. Spink. 1988. Effect of fluorophore linkage position of n-(9-anthroyloxy) fatty acids on probe distribution between coexisting gel and fluid phospholipid phases. Biochim. Biophys. Acta. 939:124-130.
39. Akashi, K., H. Miyata, H. Itoh, and K. Kinosita Jr. 1998. Formation of giant liposomes promoted by divalent cations: critical role of electrostatic repulsion. Biophys. J. 74:2973-2982.
40. Casals, C., E. Miguel, and J. Perez-Gil. 1993. Tryptophan fluorescence study on the interaction of pulmonary surfactant protein A with phospholipid vesicles. Biochem. J. 296:585-593.
41. Ruano, M. L. F., K. Nag, L. A. Worthman, C. Casals, J. Perez-Gil, and K. M. Keough. 1998. Differential partitioning of pulmonary surfactant protein SP-A into regions of monolayers of dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/dipalmitoylphosphatidylglycerol. Biophys. J. 74:1101-1109.
42. Ruano, M. L. F., K. Nag, C. Casals, J. Perez-Gil, and K. M. Keough. 1999. Interactions of pulmonary surfactant protein A with phospholipid monolayers change with pH. Biophys. J. 77:1469-1476.
43. Worthman, L. A., K. Nag, N. Rich, M. L. F. Ruano, C. Casals, J. Perez-Gil, and K. M. Keough. 2000. Pulmonary surfactant protein A interacts with gel-like regions in monolayers of pulmonary surfactant lipid extract. Biophys. J. 79:2657-2666.
44. McConnell, H. M. 1991. Structures and transitions in lipid monolayers at the air-water interface. Annu. Rev. Phys. Chem. 42:171-195.
45. McConnell, H. M., and V. T. Moy. 1988. Shapes of finite two-dimensional lipid domains. J. Phys. Chem. 98:4520-4525.
46. Casals, C., M. L. F. Ruano, E. Miguel, P. Sanchez, and J. Perez-Gil. 1994. Surfactant protein-C enhances lipid aggregation activity of surfactant protein-A. Biochem. Soc. Trans. 22:370S.
47. Bernhard, W., S. Hoffmann, H. Dombrowsky, G. A. Rau, A. Kamlage, M. Kappler, J. Haitsma, J. Freihorst, H. von der Hardt, and C. F. Poets. 2001. Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am. J. Respir. Cell Mol. Biol. 25:725-731.
48. Schurch, S., F. Possmayer, S. Cheng, and A. M. Cockshutt. 1992. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant. Am. J. Physiol. 263:L210-L218.
49. Nag, K., J. S. Pao, R. R. Harbottle, F. Possmayer, N. O. Petersen, and L. A. Bagatolli. 2002. Segregation of saturated chain lipids in pulmonary surfactant films and bilayers. Biophys. J. 82:2041-2051.
50. Walters, R. W., R. R. Jenq, and S. B. Hall. 2000. Distinct steps in the adsorption of pulmonary surfactant to an air-liquid interface. Biophys. J. 78:257-266.
51. Piknova, B., V. Schram, and S. B. Hall. 2002. Pulmonary surfactant: phase behavior and function. Curr. Opin. Struct. Biol. 12:487-494.
52. Possmayer, F., K. Nag, K. Rodriguez, R. Qanbar, and S. Schürch. 2001. Surface activity in vitro: role of surfactant proteins. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129:209-220.
53. Veldhuizen, E. J., J. J. Batenburg, L. M. van Golde, and H. P. Haagsman. 2000. The role of surfactant proteins in DPPC enrichment of surface films. Biophys. J. 79:3164-3171.
54. Baatz, J. E., V. Sarin, D. R. Absolom, C. Baxter, and J. A. Whitsett. 1991. Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface activity of model membrane bilayers. Chem. Phys. Lipids. 60:163-178.
55. Vincent, J. S., S. D. Revak, C. G. Cochrane, and I. W. Levin. 1991. Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B. Biochemistry. 30:8395-8401.
56. Schram, V., and S. B. Hall. 2004. SP-B and SP-C alter diffusion in bilayers of pulmonary surfactant. Biophys. J. 86:3734-3743.
57. Biswas, S. C., S. B. Rananavare, and S. B. Hall. 2005. Effects of gramicidin-A on the adsorption of phospholipids to the air-water interface. Biochim. Biophys. Acta. 1717:41-49.
58. Perez-Gil, J., C. Casals, and D. Marsh. 1995. Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy. Biochemistry. 34:3964-3971.